Sign in or Register   Sign in or Register
  |  

Mouse Anti-DHODH Recombinant Antibody (6E1) (CBMAB-D0838-YC)

Provided herein is a Mouse monoclonal antibody, which binds to Dihydroorotate Dehydrogenase (Quinone) (DHODH). The antibody can be used for immunoassay techniques, such as ELISA, IHC-P, WB.
See all DHODH antibodies
Published Data

Summary

Host Animal
Mouse
Specificity
Human
Clone
6E1
Antibody Isotype
IgG2a, λ
Application
ELISA, IHC-P, WB

Basic Information

Specificity
Human
Antibody Isotype
IgG2a, λ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
Dihydroorotate Dehydrogenase (Quinone)
Introduction
DHODH catalyzes the fourth enzymatic step, the ubiquinone-mediated oxidation of dihydroorotate to orotate, in de novo pyrimidine biosynthesis. This protein is a mitochondrial protein located on the outer surface of the inner mitochondrial membrane.
Entrez Gene ID
UniProt ID
Alternative Names
Dihydroorotate Dehydrogenase (Quinone); Dihydroorotate Oxidase; DHOdehase; Dihydroorotate Dehydrogenase (Quinone), Mitochondrial; Human Complement Of Yeast URA1; Dihydroorotate Dehydrogenase;
Function
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor.
Biological Process
de novo' pyrimidine nucleobase biosynthetic process Source: GO_Central
'de novo' UMP biosynthetic process Source: UniProtKB-UniPathway
Female pregnancy Source: Ensembl
Lactation Source: Ensembl
Positive regulation of apoptotic process Source: Ensembl
Pyrimidine nucleoside biosynthetic process Source: Reactome
Pyrimidine ribonucleotide biosynthetic process Source: GO_Central
Regulation of mitochondrial fission Source: Ensembl
Response to caffeine Source: Ensembl
Response to drug Source: Ensembl
Response to L-arginine Source: Ensembl
Response to starvation Source: Ensembl
Cellular Location
Mitochondrion inner membrane
Involvement in disease
Postaxial acrofacial dysostosis (POADS):
POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.
Topology
Mitochondrial matrix: 1-10
Helical: 11-30
Mitochondrial intermembrane: 31-395
PTM
The uncleaved transit peptide is required for mitochondrial targeting and proper membrane integration.

Horwitz, S. M., Blue, T. C., Ambarian, J. A., Hoshino, S., Seyedsayamdost, M. R., & Davis, K. M. (2022). Structural insights into inhibition of the drug target dihydroorotate dehydrogenase by bacterial hydroxyalkylquinolines. RSC chemical biology, 3(4), 420-425.

Sousa, F. M., Refojo, P. N., & Pereira, M. M. (2021). Investigating the amino acid sequences of membrane bound dihydroorotate: quinone oxidoreductases (DHOQOs): Structural and functional implications. Biochimica et Biophysica Acta (BBA)-Bioenergetics, 1862(1), 148321.

de Mori, R. M., Aleixo, M. A., Zapata, L. C., Calil, F. A., Emery, F. S., & Nonato, M. C. (2021). Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni. The FEBS Journal, 288(3), 930-944.

Orozco Rodriguez, J. M., Krupinska, E., Wacklin-Knecht, H., & Knecht, W. (2021). Protein production, kinetic and biophysical characterization of three human dihydroorotate dehydrogenase mutants associated with Miller syndrome. Nucleosides, Nucleotides & Nucleic Acids, 1-19.

Sato, D., Hartuti, E. D., Inaoka, D. K., Sakura, T., Amalia, E., Nagahama, M., ... & Shiba, T. (2020). Structural and biochemical features of Eimeria tenella dihydroorotate dehydrogenase, a potential drug target. Genes, 11(12), 1468.

Nonato, M. C., de Pádua, R. A., David, J. S., Reis, R. A., Tomaleri, G. P., Pereira, H. D. M., & Calil, F. A. (2019). Structural basis for the design of selective inhibitors for Schistosoma mansoni dihydroorotate dehydrogenase. Biochimie, 158, 180-190.

Calil, F. A., David, J. S., Chiappetta, E. R., Fumagalli, F., Mello, R. B., Leite, F. H., ... & Nonato, M. C. (2019). Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase. European journal of medicinal chemistry, 167, 357-366.

Reis, R. A., Calil, F. A., Feliciano, P. R., Pinheiro, M. P., & Nonato, M. C. (2017). The dihydroorotate dehydrogenases: past and present. Archives of biochemistry and biophysics, 632, 175-191.

Singh, A., Maqbool, M., Mobashir, M., & Hoda, N. (2017). Dihydroorotate dehydrogenase: a drug target for the development of antimalarials. European Journal of Medicinal Chemistry, 125, 640-651.

Kamyingkird, K., Cao, S., Tuvshintulga, B., Salama, A., Mousa, A. A., Efstratiou, A., ... & Xuan, X. (2017). Effects of dihydroorotate dehydrogenase (DHODH) inhibitors on the growth of Theileria equi and Babesia caballi in vitro. Experimental Parasitology, 176, 59-65.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-DHODH Recombinant Antibody (6E1)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare